Stocks and Investing
Stocks and Investing
Wed, July 1, 2020
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
[ Wed, Jul 01st 2020
] - WOPRAI
Tue, June 30, 2020
[ Tue, Jun 30th 2020
] - WOPRAI
[ Tue, Jun 30th 2020
] - WOPRAI
[ Tue, Jun 30th 2020
] - WOPRAI
[ Tue, Jun 30th 2020
] - WOPRAI
[ Tue, Jun 30th 2020
] - WOPRAI
Oren Livnat Maintained (VRCA) at Strong Buy with Decreased Target to $18 on, Jun 30th, 2020
Oren Livnat of HC Wainwright & Co., Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Decreased Target from $24 to $18 on, Jun 30th, 2020.
Oren has made no other calls on VRCA in the last 4 months.
There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Oren's Rating of Hold.
This is the rating of the analyst that currently disagrees with Oren
- Tim Chiang of "Northland Capital Markets" Initiated at Buy and Held Target at $21 on, Wednesday, June 24th, 2020
Contributing Sources
Similar Stocks and Investing Articles
[ Wed, Jun 24th 2020
] - WOPRAI
[ Fri, Jun 12th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, Jan 08th 2020
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Wed, May 29th 2019
] - WOPRAI
[ Thu, Oct 11th 2018
] - WOPRAI
[ Thu, Jul 12th 2018
] - WOPRAI
[ Fri, Jun 29th 2018
] - WOPRAI
[ Tue, Feb 24th 2015
] - WOPRAI